Insider trades
Eric Benevich, Director of aTYR Pharma ATYR, has filed 0 purchases and 22 sales on the open market. Over the past 12 months that comes to a net sale of $905.9K. The latest trade was on 05/11.
Eric Benevich
Director
- Company
- aTYR Pharma ATYR
- First filing
- 23/01/10
- Trades
- 73 trades
- Buys / sales
- 0 / 22
- 12-month net buying
- −$905.9K
- Last trade
- 05/11
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 25/11/28 | 25/12/02 | 5,970 sh | $151.74 | $905,887.8 | −11.7% | |
NBIX | Open-market sale10b5-1 plan | 25/02/13 | 25/02/14 | 2,154 sh2 trades | $116.73avg. | $251,426.28 | −4.6% |
| Open-market sale10b5-1 plan | 25/02/10 | 25/02/12 | 980 sh | $118.31 | $115,943.8 | −2.2% | |
| Open-market sale10b5-1 plan | 25/01/31 | 25/02/04 | 1,207 sh | $152.94 | $184,598.58 | −2.8% | |
NBIX | Open-market sale10b5-1 plan | 24/04/15 | 24/04/17 | 19,818 sh2 trades | $133.36avg. | $2,642,928.48 | −32.7% |
NBIX | Open-market sale10b5-1 plan | 24/03/14 | 24/03/15 | 75,000 sh2 trades | $139.38avg. | $10,453,500 | −64.8% |
NBIX | Open-market sale10b5-1 plan | 24/02/28 | 24/02/29 | 75,000 sh2 trades | $134.69avg. | $10,101,750 | −64.9% |
| Open-market sale10b5-1 plan | 24/02/13 | 24/02/15 | 1,098 sh | $133.01 | $146,044.98 | −2.6% | |
NBIX | Open-market sale10b5-1 plan | 24/02/06–24/02/08 | 24/02/08 | 2,260 sh2 trades | $138.68avg. | $313,419.8 | −5.4% |
| Open-market sale10b5-1 plan | 24/01/31 | 24/02/02 | 1,207 sh | $140.78 | $169,921.46 | −3.1% | |
| Open-market sale10b5-1 plan | 23/08/21 | 23/08/23 | 1,600 sh | $107.40 | $171,840 | −4.2% | |
NBIX | Open-market sale | 23/02/06–23/02/08 | 23/02/08 | 19,650 sh4 trades | $102.70avg. | $2,018,063.9 | −36.4% |
| Open-market sale | 23/01/31 | 23/02/02 | 1,207 sh | $109.95 | $132,709.65 | −6.7% | |
| Open-market sale | 23/01/06 | 23/01/10 | 400 sh | $125.00 | $50,000 | −2.5% |
